Dr. Peletskaya is a molecular biologist who serves as the Director of In Vitro Diagnostics at DiaCarta. Dr. Peletskaya has designed many novel protocols for molecular diagnostic analysis such as highly multiplexed PCR-based SNP genotyping assays. Her research has contributed to the understanding of the functional structures of retroviral proteins as related to drug resistance, cancer therapeutics, muscular system. Dr. Peletskaya has written and contributed to several scientific articles and has also presented her findings to international audiences. Dr. Peletskaya received her schooling in Russia, completing her Ph.D. in Molecular Virology at The Russian Academy of Medical Sciences. Additionally, she has supplemented her expertise in the United States with a postdoctoral fellowship at the University of Missouri. Thereafter, Dr. Peletskaya obtained a Technical Supervisor certificate from the American Board of Bioanalysis, as well as the title of High Complexity Laboratory Director in molecular genetic testing from the New York Department of Health. Dr. Peletskaya’s technical and scientific skills are complemented with a natural aptitude for managerial roles in CLIA- and CAP-certified laboratory settings. She has served as a Principal Scientist at Biolinx since 2003, where she provides consulting services at molecular genetic testing facilities. She has had project management roles in academic and startup biotech settings while simultaneously coordinating independent projects. Dr. Peletskaya has nurtured from inception several collaborative, contract research and development projects at institutions such as the National Cancer Institute at National Institute of Health, Fox Chase Cancer Center and has been awarded government research and SBIR grant funding and contract funding from NIH and universities for her research endeavors. ×  

 Dr. Peletskaya is a molecular biologist who serves as the Director of In Vitro Diagnostics at DiaCarta. Dr. Peletskaya has designed many novel protocols for molecular diagnostic analysis such as highly multiplexed PCR-based SNP genotyping assays. Her research has contributed to the understanding of the functional structures of retroviral proteins as related to drug resistance, cancer therapeutics, muscular system. Dr. Peletskaya has written and contributed to several scientific articles and has also presented her findings to international audiences. Dr. Peletskaya received her schooling in Russia, completing her Ph.D. in Molecular Virology at The Russian Academy of Medical Sciences. Additionally, she has supplemented her expertise in the United States with a postdoctoral fellowship at the University of Missouri. Thereafter, Dr. Peletskaya obtained a Technical Supervisor certificate from the American Board of Bioanalysis, as well as the title of High Complexity Laboratory Director in molecular genetic testing from the New York Department of Health. Dr. Peletskaya’s technical and scientific skills are complemented with a natural aptitude for managerial roles in CLIA- and CAP-certified laboratory settings. She has served as a Principal Scientist at Biolinx since 2003, where she provides consulting services at molecular genetic testing facilities. She has had project management roles in academic and startup biotech settings while simultaneously coordinating independent projects. Dr. Peletskaya has nurtured from inception several collaborative, contract research and development projects at institutions such as the National Cancer Institute at National Institute of Health, Fox Chase Cancer Center and has been awarded government research and SBIR grant funding and contract funding from NIH and universities for her research endeavors. ×